Genetic editing holds promise to treat incurable diseases, but the most popular method — CRISPR — sometimes does more harm than good. A new study from University of California San Diego and Yale ...

A research team led by scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI) has introduced a new ...

PlantArcBio, an Israeli ag-biotech firm, has secured patents in the U.S. and South Korea for its DIPPER platform. This ...

As the Digital Age evolves, savvy investors are turning to deep technologies like revolutionary materials and programmable ...

Institute of Animal Husbandry and Veterinary Medicine, Fujian Academy of Agricultural Sciences, Fuzhou, China New genotype Muscovy Duck Parvovirus (N-MDPV), a member of the Parvoviridae family, ...

Confectionery giant Mars Inc, has teamed up with biotechnology firm Pairwise, to develop more resilient cocoa, using CRISPR. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a ...

CRISPR Therapeutics’ gene-editing treatments are highly customized and shockingly expensive. The market is watching to see if the underlying science can be applied to treat many diseases. The company ...

CRISPR is a gene-editing tool that acts like “molecular scissors,” but using it on cancer is complex. The technology’s biggest impact so far is in research labs, helping scientists understand how ...

New purity offering, off-target analysis services and additional solutions help to bridge the gap from discovery research to clinical translation and advance CRISPR-based therapies As researchers ...